Blog

Bệnh ung thư

Nivestym Drug Information: How It Works, Who Needs It, and What To Expect

Doctor consulting with cancer patient about Nivestym

In the U.S., about 2 million new cancer cases are diagnosed each year. Chemotherapy is the most common and effective treatment for cancer, but it comes with many side effects. One such side effect is that it causes a condition known as giảm bạch cầu trung tính, in which the level of neutrophils (a type of white blood cell) becomes very low. When this happens, you become more likely to develop infections, which can be fatal if not managed well. 

Nhận hỗ trợ tài chính

(877) 778-0318

Fortunately, drugs such as Nivestym (filgrastim-aafi) can help restore white blood cells after chemotherapy. In this article, we’ll talk about everything you need to know about Nivestym in a clear and easy-to-understand way.

What Is Nivestym?

Nivestym (filgrastim-aafi) is an FDA-approved medicine used to treat neutropenia (low levels of neutrophils, a type of white blood cell) caused by chemotherapy, bone marrow transplant, or some other condition. It is a synthetic version of the naturally occurring protein called granulocyte colony-stimulating factor (G-CSF), which promotes white blood cell production. 

The FDA first approved Nivestym on July 20, 2018, as a biosimilar to Neupogen [1]. This means that there is no clinical difference between Nivestym and Neupogen, but Nivestym is less expensive.  

What Is Nivestym Used To Treat?

Nivestym (filgrastim-aafi) is a medicine that helps your body make more white blood cells, which help fight infections. It is FDA-approved for the following purposes [2][3]:

Chemotherapy-Induced Neutropenia: This medication can reduce the risk of infection in cancer patients receiving intensive chemotherapy that can lower white blood cell counts and cause fever.

Acute Myeloid Leukemia: Nivestym can help white blood cells recover faster and shorten the duration of fever in patients with acute myeloid leukemia (AML) after extensive chemotherapy.

Ghép tủy xương: After a bone marrow transplant, Nivestym can speed up white blood cell recovery and reduce the duration of severe neutropenia. 

Peripheral Blood Progenitor Cell Collection: Nivestym is used to move blood-forming stem cells into the bloodstream so they can be collected and used later for treatment.

Severe Chronic Neutropenia: Nivestym can help patients with long-term neutropenia, including congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia. It can reduce infections and related problems, such as fever and mouth sores.

How Does Nivestym Work?

Neutrophils are a kind of white blood cell that fight bacterial and fungal infections. They are produced in your bone marrow. Unfortunately, chemotherapy and radiation therapy can harm your bone marrow, which can reduce or stop neutrophil production. This increases your chance of having serious infections.

Nivestym is a synthetic version of a naturally occurring protein called granulocyte colony-stimulating factor (G-CSF). It works by encouraging your bone marrow to:

  • Produce more neutrophils
  • Speed up neutrophil production
  • Release neutrophils into the bloodstream

As a result, your neutrophil count increases faster, reducing the time your immune system is weakened after chemotherapy. 

Tác dụng phụ

Like any other medication, Nivestym can also cause some side effects. Most are mild to moderate, but some can be severe. Here are some of the side effects of Nivestym [2][3]:

Tác dụng phụ thường gặp

Patient experiencing muscle pain, a side effect of using Nivestym
  • Bone Pain
  • Muscle Pain
  • Đau đầu
  • Mệt mỏi
  • Buồn nôn
  • Injection site reaction (redness, swelling, or pain)
  • Tiêu chảy và nôn mửa

Bone pain is the most common side effect because your bone marrow is working harder to produce more white blood cells. It is usually manageable with mild pain medicines. 

Nói chuyện với một chuyên gia

Về Trợ cấp đồng thanh toán
Lên lịch tư vấn

Tác dụng phụ nghiêm trọng

Serious side effects from Nivestym are rare but can happen. Here are some serious side effects of Nivestym:

Vỡ lách: In rare cases, Nivestym can cause rupture in your spleen, which can be fatal. Symptoms include pain in the upper left abdomen or shoulder.

Hội chứng suy hô hấp cấp tính (ARDS): Nivestym can cause ARDS in some patients. Symptoms include shortness of breath, rapid breathing, and low oxygen levels.

Phản ứng dị ứng nghiêm trọng: You may experience allergic reactions to Nivestym, particularly with the initial dose. Symptoms include rash, swelling of the face or throat, dizziness, or difficulty breathing. 

Capillary Leak Syndrome: This is a rare but serious condition where fluid leaks from your blood vessels. This leads to low blood pressure and swelling.

Sickle Cell Disorders: Nivestym can cause sickle cell crisis in patients with sickle cell disorder. This can be fatal. Discontinue Nivestym if a sickle cell crisis occurs.

Low Platelet Count: Nivestym can lower your platelet count, which can be severe.

Các vấn đề về thận: Nivestym can cause inflammation in your kidneys. Symptoms include dark-colored urine and swelling in the face, hands, or feet.

Please note that this is not a complete list of all possible side effects. Consult your doctor immediately if you experience any severe side effects of Nivestym.

Thông tin liều lượng

The dosage of Nivestym depends on your body weight and medical condition. Your doctor will determine the right dosage for you based on your condition. Here is the usual recommended dosage [3]:

For Cancer Patients Receiving Chemotherapy (including AML treatment): The usual starting dose is 5 micrograms per kilogram of your body weight per day (5 mcg/kg/day). 

For Cancer Patients Undergoing a Bone Marrow Transplant: The recommended dose is 10 mcg/kg/day. It is given as an IV infusion that lasts no longer than 24 hours.

For Patients Undergoing Autologous Stem Cell Therapy: The recommended dose is 10 mcg/kg/day. You will receive it as an injection under the skin. Your doctor will start at least 4 days before the first stem cell collection and continue until the final collection is completed.

For Patients With Congenital Neutropenia: The starting dose is 6 mcg/kg. You will receive it via an injection under your skin twice daily.

Patients with Cyclic or Idiopathic Neutropenia: The recommended starting dose is 5 mcg/kg/day.

Before Starting Nivestym

Before you start your treatment with Nivestym, have a detailed discussion with your doctor to ensure that the medicine is safe and appropriate. Tell your doctor if you:

  • Have osteoporosis (a bone disease that causes bones to become weak and prone to fracture)
  • Have allergies to thuốc filgrastim hoặc pegfilgrastim
  • Have sickle cell disease because Nivestym can trigger life-threatening complications.
  • Have a history of bone marrow disorders
  • Có vấn đề về thận
  • Have ever had an enlarged spleen or splenic rupture
  • Experience difficulty breathing or cough
  • Are pregnant or planning to become pregnant. There is limited data on its safety during pregnancy. You should only use this medication during pregnancy if your doctor thinks the potential benefits outweigh the risks.
  • Đang cho con bú
  • Are taking other prescription medicines, over-the-counter drugs, or herbal supplements

Talk With a Copay Assistance Specialist

(877) 778-0318

Trị giá

Nivestym is available in single-dose vials and prefilled syringes in various strengths. One common option is 300 mcg/ml, where a package of 10 single-dose vials (1 ml each) costs around $2,147 [4]. However, the actual price depends on your insurance plan, location, and the pharmacy you visit. Liên hệ với chúng tôi if you are interested in exploring financial assistance options for Nivestym.

TÀI LIỆU THAM KHẢO:

  1. Pfizer Inc. (n.d.). U.S. FDA Approves Pfizer’s Biosimilar NIVESTYMTM (filgrastim-aafi) | Pfizer. https://www.pfizer.com/news/press-release/press-release-detail/u_s_fda_approves_pfizer_s_biosimilar_nivestym_filgrastim_aafi-0
  2. Home Page | NIVESTYM (filgrastim-aafi) HCP Website | Safety Info. (n.d.). https://nivestym.pfizerpro.com/
  3. HIGHLIGHTS OF PRESCRIBING INFORMATION. (2025). https://labeling.pfizer.com/ShowLabeling.aspx?id=10899
  4. Nivestym Prices, Coupons, Copay Cards & Patient Assistance. (n.d.). Drugs.com. https://www.drugs.com/price-guide/nivestym
Thông tin này không thay thế cho lời khuyên hoặc phương pháp điều trị y tế. Hãy trao đổi với bác sĩ hoặc nhà cung cấp dịch vụ chăm sóc sức khỏe về tình trạng sức khỏe của bạn trước khi bắt đầu bất kỳ phương pháp điều trị mới nào. AmeriPharma® Specialty Care không chịu bất kỳ trách nhiệm nào đối với thông tin được cung cấp hoặc đối với bất kỳ chẩn đoán hoặc phương pháp điều trị nào được đưa ra do thông tin này, cũng như không chịu trách nhiệm về độ tin cậy của nội dung. AmeriPharma® Specialty Care không vận hành tất cả các trang web/tổ chức được liệt kê ở đây, cũng không chịu trách nhiệm về tính khả dụng hoặc độ tin cậy của nội dung của họ. Các danh sách này không ngụ ý hoặc cấu thành sự chứng thực, tài trợ hoặc khuyến nghị của AmeriPharma® Specialty Care. Trang web này có thể chứa các tham chiếu đến các loại thuốc theo toa có tên thương hiệu là nhãn hiệu hoặc nhãn hiệu đã đăng ký của các nhà sản xuất dược phẩm không liên kết với AmeriPharma® Specialty Care.
Dr. Mark Alfonso
ĐÃ ĐƯỢC XEM XÉT Y KHOA BỞI Tiến sĩ Mark Alfonso, Dược sĩ, BCMTMS

Tiến sĩ Mark Alfonso, PharmD sinh ra và lớn lên tại Pueblo, CO. Ông nhận bằng dược sĩ từ Khoa Dược của Đại học Colorado tại Cơ sở Y khoa Anschutz vào năm 2010. Ông được cấp chứng chỉ quản lý liệu pháp thuốc vào năm 2022. Phần bổ ích nhất trong công việc của ông là giúp trả lời các câu hỏi và mối quan tâm của bệnh nhân. Các lĩnh vực chuyên môn của ông là quản lý dược phẩm cộng đồng và liệu pháp thuốc. Trong thời gian rảnh rỗi, ông thích đọc sách và chạy bộ.

Liên hệ với chúng tôi

If you are interested in speaking to a specialist or wish to explore financial assistance opportunities, use the contact form below to get in touch with us.

HIPAA Compliant

Bằng cách gửi, bạn đồng ý với AmeriPharma Điều khoản sử dụng, Chính sách bảo mật, Và Thông báo về Thực hành Bảo mật